title: [What does the urologist expect and hope for from the pathologist in diagnosis of prostate carcinoma].
abstract: Prostate cancer has become the most common cancer in males in Western countries. In the United States 317,000 men were newly diagnosed with this disease in 1996. Screening efforts will identify increasing numbers of men who will be scheduled for prostate biopsy. Since the progression of prostate cancer varies widely from rapid tumor growth with early distant metastases to slow growth with good prognosis, it is of utmost importance that prognostic parameters be identified which allow the course of the disease to be predicted. Thus, the correct pathohistological staging, the evaluation of different grading systems, and the biological impact of positive surgical margins after radical prostatectomy requires collaboration between urologists and pathologists.
authors.affiliation: Urologische Klinik, Technischen Universität München, Klinikum rechts der Isar.
authors.forename: J
authors.initials: J
authors.lastname: Breul
authors.forename: R
authors.initials: R
authors.lastname: Hartung
mesh_terms: D001706:Biopsy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D010348:Patient Care Team; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery
vernacular_title: Was erwartet und erhofft der Urologe vom Pathologen in der Diagnostik des Prostatakarzinoms?